John E Wagner

Medicine & Life Sciences

1. Fetal Blood 100%
2. Transplantation 63%
3. Transplants 49%
4. Graft vs Host Disease 48%
5. Unrelated Donors 46%
6. Cell Transplantation 42%
7. Tissue Donors 34%
8. Bone Marrow 32%
9. Fanconi Anemia 32%
10. Bone Marrow Transplantation 26%
11. Hematopoietic Stem Cell Transplantation 25%
12. Hematopoietic Stem Cells 19%
13. Leukemia 19%
14. Allogeneic Cells 18%
15. Siblings 18%
16. Stem Cells 18%
17. Survival 16%
18. Homologous Transplantation 15%
19. Child 13%
20. Recurrence 13%
21. HLA Antigens 11%
22. T-Lymphocytes 11%
23. Blood Cells 10%
24. Mortality 9%
25. Pediatrics 9%
26. Natural Killer Cells 8%
27. fludarabine 8%
28. Confidence Intervals 8%
29. Precursor Cell Lymphoblastic Leukemia-Lymphoma 8%
30. Epidermolysis Bullosa Dystrophica 8%
31. Hematologic Neoplasms 7%
32. Incidence 7%
33. Regulatory T-Lymphocytes 7%
34. Epidermolysis Bullosa 7%
35. Antilymphocyte Serum 7%
36. Whole-Body Irradiation 7%
37. Neutrophils 7%
38. Therapeutics 7%
39. Cyclophosphamide 7%
40. Acute Myeloid Leukemia 7%
41. Blood Banks 6%
42. Cyclosporine 6%
43. Mycophenolic Acid 6%
44. Busulfan 6%
45. Myelodysplastic Syndromes 5%
46. Peripheral Blood Stem Cells 5%
47. Stem Cell Transplantation 5%
48. Bone Marrow Cells 5%
49. Lymphocytes 5%
50. Mucopolysaccharidosis I 5%